DocMeetings

Configurable RTSM systems present new opportunities to accelerate adoption of clinical trial platforms, while lowering the total cost of ownership. As the industry continues to move away from cumbersome custom solutions, new questions arise about how to standardize approaches to RTSM ownership, manage platform adoption, conduct site and sponsor training, perform cross-study analytics and reporting, and achieve economies of scale.

Key Learning Objectives:

• Learn how NeoTX is making new discoveries in cancer therapy.
• Learn how a configurable RTSM system plays a crucial role in their clinical trial operations.
• Learn how NeoTX is using data to drive organizational decision-making.
• Learn how configurable RTSM solutions allow for standardization viaValidated approaches
  Site and sponsor training
  Help documentation and support